6551 - 6560 of 9034 Results
Title
Year
-
OPENTitle: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 17Start Page: 13435End Page: 13435Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241713435Best OA location URL: https://www.mdpi.com/1422-0067/24/17/13435/pdf?version=1693464631Citation Count: 6
- Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensor2016RESTRICTEDTitle: Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensorJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 263Issue #: 8Start Page: 1544End Page: 1551Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-016-8164-6Citation Count: 49
-
OPENTitle: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MSJournal Name: Clinical BiochemistryPublisher: Elsevier BVVol: 72Issue #:Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006Best OA location URL: https://doi.org/10.1016/j.clinbiochem.2019.05.006Citation Count: 47
- Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins2017RESTRICTEDTitle: Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteinsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 134Issue #: 4Start Page: 629End Page: 653Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-017-1722-xCitation Count: 266
-
OPENTitle: The interplay between stress, inflammation and Parkinson’s disease: insights from the COVID-19 pandemicJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 333End Page: 333Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01178-7Best OA location URL: https://www.nature.com/articles/s41531-025-01178-7.pdfCitation Count: 1
-
OPENTitle: Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 6Issue #: 3Start Page: 101999End Page: 101999Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2025.101999Best OA location URL: https://www.cell.com/action/showPdf?pii=S2666379125000722Citation Count: 22
-
OPENTitle: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stageJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 213Issue #:Start Page: 107018End Page: 107018Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107018Citation Count: 2
-
OPENTitle: Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face ValidityJournal Name: SensorsPublisher: MDPI AGVol: 20Issue #: 11Start Page: 3216End Page: 3216Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s20113216Best OA location URL: https://www.mdpi.com/1424-8220/20/11/3216/pdf?version=1591769863Citation Count: 48
- Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 939Issue #:Start Page: 175429End Page: 175429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429Citation Count: 6
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1